| Catalog No. | HV643026 |
|---|
| Species reactivity | Human |
|---|
| Applications | Research Grade Biosimilar |
|---|
| Host species | Human |
|---|
| Isotype | Fusion - ALB (albumin, human serum albumin, HSA) 25-609 - CSF3 (colony stimulating factor 3, GCSF, granulocyte colony-stimulating factor, G-CSF) |
|---|
| Expression system | Mammalian Cells |
|---|
| Target | G-CSF receptor, CSF3R, GCSFR, G-CSF-R, CD114, Granulocyte colony-stimulating factor receptor |
|---|
| Concentration | 0.5mg/ml |
|---|
| Endotoxin level | Please contact the lab for this information. |
|---|
| Purity | >95% purity as determined by SDS-PAGE. |
|---|
| Purification | Purified by ion exchange chromatography. |
|---|
| Accession | Q99062 |
|---|
| Form | Liquid |
|---|
| Storage buffer | 0.01M PBS,pH7.4. |
|---|
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -1474°C. |
|---|
| Alternate Names | ALB-rG-CSF,G-CSF-HAS,HSA-rG-CSF,EGRANLI™,NEUGRANIN™,ALBUGRANIN™ |
|---|
| Background | Balugrastim (CG 10639) is a novel long-acting recombinant granulocyte colony-stimulating factor (G-CSF) obtained by means of a genetic fusion between recombinant human serum albumin and granulocyte colony-stimulating factor. Balugrastim can be used for the research of breast cancer. |
|---|
| Note | For research use only. Not for use in clinical or therapeutic applications. |
|---|
